Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)
Latest Information Update: 07 Oct 2021
At a glance
- Drugs Apixaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms AEGEAN
- Sponsors Bristol-Myers Squibb
- 26 Jun 2019 Results assessing the impact of an educational program on adherence and persistence with apixaban in patients with non-valvular atrial fibrillation published in the American Journal of Cardiovascular Drugs
- 16 Nov 2016 Results of adherence and persistence to apixaban treatment presented at the 89th Annual Scientific Sessions of the American Heart Association
- 09 Sep 2016 Status changed from active, no longer recruiting to completed.